Portal de Periódicos da CAPES

Pseudo‐chilblain lesions and COVID‐19: a controversial relationship

2021; Wiley; Volume: 60; Issue: 6 Linguagem: Inglês

10.1111/ijd.15422

1365-4632

I. Vázquez‐Osorio, Lucía Rocamonde, Mercedes Treviño‐Castellano, H. Vázquez‐Veiga, Manuel Ginarte Val,

Streptococcal Infections and Treatments

International Journal of DermatologyVolume 60, Issue 6 p. 754-756 Correspondence Pseudo-chilblain lesions and COVID-19: a controversial relationship Igor Vázquez-Osorio MD, Corresponding Author Igor Vázquez-Osorio MD [email protected] orcid.org/0000-0001-7708-2997 Department of Dermatology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorLucía Rocamonde MD, Lucía Rocamonde MD Department of Clinical Analysis, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorMercedes Treviño-Castellano MD, Mercedes Treviño-Castellano MD Department of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorHugo Vázquez-Veiga MD, Hugo Vázquez-Veiga MD Department of Dermatology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorManuel Ginarte PhD, Manuel Ginarte PhD orcid.org/0000-0002-7030-7484 Department of Dermatology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this author Igor Vázquez-Osorio MD, Corresponding Author Igor Vázquez-Osorio MD [email protected] orcid.org/0000-0001-7708-2997 Department of Dermatology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorLucía Rocamonde MD, Lucía Rocamonde MD Department of Clinical Analysis, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorMercedes Treviño-Castellano MD, Mercedes Treviño-Castellano MD Department of Microbiology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorHugo Vázquez-Veiga MD, Hugo Vázquez-Veiga MD Department of Dermatology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this authorManuel Ginarte PhD, Manuel Ginarte PhD orcid.org/0000-0002-7030-7484 Department of Dermatology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, EspañaSearch for more papers by this author First published: 09 February 2021 https://doi.org/10.1111/ijd.15422Citations: 6 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Galván Casas C, Catalá A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183: 71–77. 10.1111/bjd.19163 CASPubMedWeb of Science®Google Scholar 2Docampo-Simón A, Juan G, Poveda-Montoyo I, et al. Are chilblain-like acral skin lesions really indicatative of COVID-19? A prospective study and literature review. J Eur Acad Dermatol Venereol 2020; 34: e445–e447. 10.1111/jdv.16665 CASPubMedWeb of Science®Google Scholar 3Hubiche T, Cardot-Leccia N, Le Duff F, et al. Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol 2020:e204324. https://doi.org/10.1001/jamadermatol.2020.4324 Web of Science®Google Scholar 4Freeman EE, McMahon DE, Lipoff JB, et al. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries. J Am Acad Dermatol 2020; 83: 486–492. 10.1016/j.jaad.2020.05.109 CASPubMedWeb of Science®Google Scholar 5Kolivras A, Dehavay F, Delplace D, et al. Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathological findings. JAAD Case Rep 2020; 6: 489–492. 10.1016/j.jdcr.2020.04.011 PubMedGoogle Scholar 6Dammacco F, Lauletta G, Russi S, et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med 2019; 19: 1–21. 10.1007/s10238-018-0536-z CASPubMedWeb of Science®Google Scholar Citing Literature Volume60, Issue6June 2021Pages 754-756 This article also appears in:International Journal of Dermatology COVID-19 Papers ReferencesRelatedInformation